Quetiapine May Be Better Option Than Lithium for Treatment-Resistant Depression
(MedPage Today) -- Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter clinical trial suggested.
Over...
Read more »